Presentations will highlight the patient experience of cannabis withdrawal/cannabis use disorder and Phase 2 CAN-002 data for investigational PP-01 in adults with cannabis use disorder PHOENIXVILLE, Pa., June 15, 2026 /PRNewswire/ -- PleoPharma, a clinical-stage clinical development...
Hence then, the article about pleopharma to present newdata on cannabis withdrawal in patients with cannabis use disorder and phase 2 pp 01 results at the college on problems of drug dependence 88th annual scientific meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING )
Also on site :
- Did 'Summer House: The Aftermath' Just Hard Launch Amanda Batula's Redemption Arc? Some Fans Say 'Too Late'
- A Shocking Recoupling! And the Second Vote Opens! Who Are the New Couples of ‘Love Island USA’ 2026
- Home Invader Arrested After Woman Shot Him for Threatening Her and Her Kids